SG153727A1 - Substituted pyridinones as modulators of p38 map kinase - Google Patents
Substituted pyridinones as modulators of p38 map kinaseInfo
- Publication number
- SG153727A1 SG153727A1 SG200808207-5A SG2008082075A SG153727A1 SG 153727 A1 SG153727 A1 SG 153727A1 SG 2008082075 A SG2008082075 A SG 2008082075A SG 153727 A1 SG153727 A1 SG 153727A1
- Authority
- SG
- Singapore
- Prior art keywords
- compounds
- map kinase
- modulators
- substituted pyridinones
- disclosed
- Prior art date
Links
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title abstract 2
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 title abstract 2
- 150000005299 pyridinones Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed are compounds of Formula (1) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG200808207-5A SG153727A1 (en) | 2003-02-14 | 2003-02-14 | Substituted pyridinones as modulators of p38 map kinase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG200808207-5A SG153727A1 (en) | 2003-02-14 | 2003-02-14 | Substituted pyridinones as modulators of p38 map kinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG153727A1 true SG153727A1 (en) | 2009-07-29 |
Family
ID=40901939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200808207-5A SG153727A1 (en) | 2003-02-14 | 2003-02-14 | Substituted pyridinones as modulators of p38 map kinase |
Country Status (1)
| Country | Link |
|---|---|
| SG (1) | SG153727A1 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997010712A1 (en) * | 1995-09-19 | 1997-03-27 | Margolin Solomon B | Inhibition of tumor necrosis factor alpha |
-
2003
- 2003-02-14 SG SG200808207-5A patent/SG153727A1/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997010712A1 (en) * | 1995-09-19 | 1997-03-27 | Margolin Solomon B | Inhibition of tumor necrosis factor alpha |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
| TW200517109A (en) | Substituted pyridinones | |
| MXPA05010621A (en) | Substituted pyrimidinones. | |
| TWI255807B (en) | Therapeutic agents | |
| MXPA05009359A (en) | 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators. | |
| MY140693A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| MXPA05006420A (en) | Pyrimidine derivates for the treatment of abnormal cell growth. | |
| MXPA05012678A (en) | CRYSTALLINE FORM OF beta2. | |
| GB0112348D0 (en) | Compounds | |
| AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
| SE0400043D0 (en) | New compounds | |
| MXPA06009475A (en) | Quinazoline derivatives and therapeutic use thereof. | |
| CY1109366T1 (en) | Substituted Compounds 1,4,8-Triazazepiro [4.5] Decan-2-One | |
| EP1725536B8 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
| HRP20010969B1 (en) | Novel piperazinylalkylthiopyrimidine derivatives, | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| MXPA05004273A (en) | Phenylalkyl and pyridylalkyl piperazine derivatives. | |
| MXPA04005313A (en) | Aminotetralin derivatives as muscarinic receptor antagonists. | |
| NO20053809L (en) | Diarylmethylindenepiperidine derivatives, process for their preparation, and use thereof | |
| MXPA04000036A (en) | (hetero) aryl substituted benzofurans as 5-ht ligands. | |
| MXPA04005151A (en) | Therapeutic compounds. | |
| UA81405C2 (en) | Substituted pyridinones as modulators of p38 map kinase | |
| MXPA04001201A (en) | Tetracyclic indole derivatives as 5-ht receptor ligands. | |
| NO20053805L (en) | Diarylmethylindenepiperidine derivatives, processes for their preparation, and use thereof | |
| SG153727A1 (en) | Substituted pyridinones as modulators of p38 map kinase |